Agreed with you to go after AU/Japan first and a few other Industriazed countries. They have a better chance to generate a lot of revenue quickly. While they are at it they can collect and monitor some patients for future data before they approach FDA . If data is solid which I expect that I do not see any objection from FDA to approve our drug.